Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical & Medical Microbiology Volume 1 (2016), Article ID 1:IJCMM-101, 2 pages
https://doi.org/10.15344/2456-4028/2016/101
Commentary
A Putative Fifth Serotype of Dengue - Potential Implications for Diagnosis, Therapy and Vaccine Design

Andrew W. Taylor-Robinson

School of Medical & Applied Sciences, Central Queensland University, Rockhampton, QLD 4702, Australia
Prof Andrew W. Taylor-Robinson, School of Medical & Applied Sciences, Central Queensland University, Bruce Highway, Rockhampton, QLD 4702, Australia. Tel: +61 7 4923 2008; E-mail: a.taylor-robinson@cqu.edu.au
08 December 2015; 28 February 2016; 03 March 2016
Taylor-Robinson AW (2016) A Putative Fifth Serotype of Dengue - Potential Implications for Diagnosis, Therapy and Vaccine Design. Int J Clin Med Microbiol 1: 101. doi: https://doi.org/10.15344/2456-4028/2016/101
© 2016 Taylor-Robinson. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. WHO (2009) Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization. 160 pp [Google Scholar]
  2. slam R, Salahuddin M, Ayubi MS, Hossain T, Majumder A, et al. (2015) Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past. Virol Sin 30: 326-343 [CrossRef] [Google Scholar] [PubMed]
  3. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504-507 [CrossRef] [Google Scholar] [PubMed]
  4. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-496 [CrossRef] [Google Scholar] [PubMed]
  5. Halstead SB (2007) Dengue. Lancet 370: 1644-1652 [CrossRef] [Google Scholar] [PubMed]
  6. Burke DS, Monath TP (2001) Flavivirus. In: Knipe DM, Howley PM (Eds) Fields Virology (vol 1, 4th ed), Philadelphia: Lippincott Williams & Wilkins 1043-1126
  7. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-S16 [CrossRef] [Google Scholar] [PubMed]
  8. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, et al. (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156: 40-51 [CrossRef] [Google Scholar] [PubMed]
  9. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, et al. (1999) Dengue virus structural differences that correlate with pathogenesis. J Virol 73: 4738-4747 [Google Scholar] [PubMed]
  10. Sanyal S, Taylor-Robinson AW (2013) Host-virus interactions in dengue infection indicate targets for detection and therapeutic interventions. Immun Dis 1: 71-74 [CrossRef]
  11. Ansari S, Taylor-Robinson AW (2014) Strategic approaches to multivalent vaccine development against dengue virus infection. Annal Vaccines Immunization 1: 1005-1012
  12. Halstead SB, Heinz FX, Barrett AD, Roehrig JT (2005) Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine 23: 849-856 [CrossRef] [Google Scholar] [PubMed]
  13. Normile D (2013) Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science 342: 415 [CrossRef] [Google Scholar] [PubMed]
  14. da Silva Voorham JM (2014) [A possible fifth dengue virus serotype]. Ned Tijdschr Geneeskd 158: A7946 [Google Scholar] [PubMed]
  15. Mustafa MS, Rasotgi V, Jain S, Gupta V (2015) Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India 71: 67-70 [CrossRef] [Google Scholar] [PubMed]
  16. Wiwanitkit S, Wiwanitkit V (2015) Acute viral hemorrhage disease: a summary on new viruses. J Acute Dis 4: 277-279 [CrossRef] [Google Scholar]
  17. Vasilakis N, Durbin AP, da Rosa AP, Munoz-Jordan JL, Tesh RB, et al. (2008) Antigenic relationships between sylvatic and endemic dengue viruses. Am J Trop Med Hyg 79: 128-132 [CrossRef] [Google Scholar] [PubMed]
  18. Inoue S, Morita K, Matias RR, Tuplano JV, Resuello RR, et al. (2003) Distribution of three arbovirus antibodies among monkeys (Macaca fascicularis) in the Philippines. J Med Primatol 32: 89-94 [CrossRef] [Google Scholar] [PubMed]
  19. Hirschmann JV (1997) Fever of unknown origin in adults. Clin Infect Dis 24: 291-300 [CrossRef] [Google Scholar] [PubMed]
  20. Efstathiou SP Pefanis AV, Tsiakou AG, Skeva II, Tsioulos DI, et al. (2010) Fever of unknown origin: discrimination between infectious and noninfectious causes. Eur J Intern Med 21: 137-143 [CrossRef] [Google Scholar] [PubMed]
  21. Susilawati TN, McBride WJ (2014) Undiagnosed undifferentiated fever in Far North Queensland, Australia: a retrospective study. Int J Infect Dis 27: 59-64 [CrossRef] [Google Scholar] [PubMed]
  22. Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, et al. (2010) Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis 4: e787 [CrossRef] [Google Scholar] [PubMed]
  23. Jentes ES, Robinson J, Johnson BW, Conde I, Sakouvougui Y, et al. (2010) Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg 83: 388-394 [CrossRef] [Google Scholar] [PubMed]
  24. Subedi D, Taylor-Robinson AW (2014) Laboratory diagnosis of dengue infection: current techniques and future strategies. Open J Clin Diagn 4: 63-70 [CrossRef] [Google Scholar]
  25. Liang G, Gao X, Gould EA (2015) Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infect 4: e18 [CrossRef] [Google Scholar] [PubMed]
  26. Subedi D, Taylor-Robinson AW (2015) Development of a dengue vaccine in humans: so near, yet so far. SOJ Vaccine Res 1: 7-13 [Google Scholar]
  27. Vannice KS, Roehrig JT, Hombach J (2015) Next generation dengue vaccines: A review of the preclinical development pipeline. Vaccine 33: 7091-7099 [CrossRef] [Google Scholar] [PubMed]
  28. Coller BA, Clements DE (2011) Dengue vaccines: progress and challenges. Curr Opin Immunol 23: 391-398 [CrossRef] [Google Scholar] [PubMed]
  29. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9 [CrossRef] [Google Scholar] [PubMed]
  30. Whitehead SS, Falgout B, Hanley KA, Blaney JE Jr, Markoff L, et al. (2003) A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. J Virol 77: 1653-1657 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.